header-medias

GlioCure selected at the 3rd International Biotechnology Meetings and FTTI 2018

normal

After its participation on February 7, 2018 in the 3rd International Biotechnology Meetings organized by LEEM and BpiFrance, GlioCure was again selected to present GC01, its new generation anti-glioblastoma peptide, to a panel of European investors during the France Tech Transfer Invest 2018 which will be held on February 13 and 14 at the BpiFrance Hub 8 boulevard Haussmann in Paris 9ème
The event, jointly organized by Tech Tour, the SATT network, BPI France and EuroQuity, will feature 40 start-ups accompanied by the SATT network, including 10 from the biotechnology sector.

Retour